MurrayIRChahlaJSafranMR, et al. International expert consensus on a cell therapy communication tool: DOSES. J Bone Joint Surg Am. 2019;101(10):904-911.
2.
MurrayIRGeeslinAGGoudieEBPetriglianoFALaPradeRF. Minimum information for studies evaluating biologics in orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J Bone Joint Surg Am. 2017;99(10):809-819.
3.
OudelaarBWPeerboomsJCHuisin‘t VeldRVochtelooAJH. Concentrations of blood components in commercial platelet-rich plasma separation systems: a review of the literature. Am J Sports Med. 2019;47(2):479-487.
4.
PagetLDABierma-ZeinstraSMAGoedegebuureS, et al. Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled trial. BMJ Open. 2019;9(10):e030961.
5.
PagetLDAReurinkGde VosR-J, et al. Effect of platelet-rich plasma injections vs placebo on ankle symptoms and function in patients with ankle osteoarthritis: a randomized clinical trial. JAMA. 2021;326(16):1595-1605.
6.
PagetLDAReurinkGde VosR-J, et al. Platelet-rich plasma injections for the treatment of ankle osteoarthritis. Am J Sports Med. 2023;51(10):2625-2634.
7.
ReurinkGGoudswaardGJMoenMH, et al. Rationale, secondary outcome scores and 1-year follow-up of a randomised trial of platelet-rich plasma injections in acute hamstring muscle injury: the Dutch Hamstring Injection Therapy study. Br J Sports Med. 2015;49(18):1206-1212.
